Home
>
US Stocks
>
Affimed N.V.
Affimed N.V.
AFMD

Affimed N.V.

$5.9212.3%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
6.05
Today Low/High
5.92 / 6.05
52 Week Low/High
$3.07 / $11.74
Market Cap
$572.03M

Company Details

Affimed is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer by actualizing the untapped potential of the innate immune system. The company's proprietary ROCK® platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. The ROCK platform predictably generates customized innate cell engager (ICE®) molecules, which use patients' immune cells to destroy tumor cells. This innovative approach enabled Affimed to become the first company with a clinical-stage ICE®. Headquartered in Heidelberg, Germany, with offices in New York, New York, Affimed is led by an experienced team of biotechnology and pharmaceutical leaders united by a bold vision to stop cancer from ever derailing patients' lives.
Organisation
Affimed N.V.
Employees
158
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Affimed N.V. share price today

Can Indians buy Affimed N.V. shares?

How can I buy Affimed N.V. shares from India?

Can Fractional shares of Affimed N.V. be purchased?

What are the documents required to start investing in Affimed N.V. stocks?

We are a SEBI registered investement advisor